VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 51 filers reported holding VERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,051,359 | -9.0% | 295,504 | +6.5% | 0.00% | 0.0% |
| Q2 2023 | $4,453,281 | +196.8% | 277,463 | +43.5% | 0.00% | – |
| Q1 2023 | $1,500,668 | -38.2% | 193,385 | +54.1% | 0.00% | -100.0% |
| Q4 2022 | $2,428,057 | -0.8% | 125,481 | +9.2% | 0.00% | 0.0% |
| Q3 2022 | $2,448,000 | +59.9% | 114,870 | +2.1% | 0.00% | – |
| Q2 2022 | $1,531,000 | -40.4% | 112,470 | +2.8% | 0.00% | – |
| Q1 2022 | $2,570,000 | +23.6% | 109,407 | +40.5% | 0.00% | – |
| Q4 2021 | $2,080,000 | +102.1% | 77,853 | +31.3% | 0.00% | – |
| Q3 2021 | $1,029,000 | – | 59,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |